| COX-2抑制剂与乳腺癌关系研究进展 |
| |
| 引用本文： | 战淑珺,江泽飞,宋三泰. COX-2抑制剂与乳腺癌关系研究进展[J]. 癌症进展, 2005, 3(1): 45-48,79 |
| |
| 作者姓名： | 战淑珺 江泽飞 宋三泰 |
| |
| 作者单位： | 军事医学科学院,307医院乳腺癌内科,北京,100039;军事医学科学院,307医院乳腺癌内科,北京,100039;军事医学科学院,307医院乳腺癌内科,北京,100039 |
| |
| 摘 要： | COX-2是前列腺素合成的重要限速酶,在乳腺癌中有表达.初步研究表明,COX-2选择性抑制剂对乳腺癌有化学预防及治疗作用,并与乳腺癌现有治疗手段有相加作用,有望成为肿瘤防治的新靶点.
|
| 关 键 词： | COX-2 COX-2抑制剂 乳腺癌 |
Progress of relationship in COX-2 inhibitor and breast cancer |
| |
| Zhan Shujun Jiang Zefei # Song Santai. Progress of relationship in COX-2 inhibitor and breast cancer[J]. Oncology Progress, 2005, 3(1): 45-48,79 |
| |
| Authors: | Zhan Shujun Jiang Zefei # Song Santai |
| |
| Affiliation: | Zhan Shujun Jiang Zefei # Song SantaiDepartment of Breast Cancer,N0.307 Hospital,Academey of Military Medical Sciences,Beijing 100039,China |
| |
| Abstract: | COX-2 is the rate-limiting enzyme in prostaglandin biosynthesis,and is over-expressed in breast cancer.Recent studies suggest that COX-2 inhibitor is effective in chemoprevention and treatment for breast cancer.Also it is in combination with the current therapy.So COX may be a promising target for tumor chemoprevention and treatment. |
| |
| Keywords: | COX-2 COX-2 inhibitor breast cancer |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
